Financing ·
Integra LifeSciences raises $450M via 9.5% secured notes and refinances debt with $1.65B credit facility
IARTIntegra Lifesciences Holdings Corp
Integra LifeSciences Holdings Corporation completed a private offering of $450 million in aggregate principal amount of 9.500% Senior Secured Notes due November 2033. Concurrently, the company entered into an amended and restated credit agreement providing up to $1.65 billion in financing, consisting of a $600 million senior secured revolving facility, a $600 million Term Loan A facility, and a $450 million Term Loan B facility. The company utilized proceeds from the notes and borrowings under the new credit facility to repay its existing $1.3 billion revolving credit facility and $775 million term loan facility in full. Integra LifeSciences is a global medical technology leader focused on neurosurgery and tissue reconstruction.